Rosetta Genomics Ltd
OTC:ROSGQ
Rosetta Genomics Ltd
OTC:ROSGQ
Price:
0.0001 USD
Market Closed
Updated:
May 16, 2024
Rosetta Genomics Ltd
Research & Development
|
Rosetta Genomics Ltd
Research & Development Peer Comparison
Comparables:
CLGN
KMDA
URGN
ENTX
B
BONS
Competitive Research & Development Analysis
Latest Figures & CAGR of Competitors
Latest Figures & CAGR of Competitors
| Company | Research & Development | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
|---|---|---|---|---|---|
|
|
Rosetta Genomics Ltd
OTC:ROSGQ
|
Research & Development
-$3.2m
|
CAGR 3-Years
-22%
|
CAGR 5-Years
1%
|
CAGR 10-Years
N/A
|
|
|
Collplant Biotechnologies Ltd
NASDAQ:CLGN
|
Research & Development
-$10.5m
|
CAGR 3-Years
-42%
|
CAGR 5-Years
-21%
|
CAGR 10-Years
N/A
|
|
|
Kamada Ltd
NASDAQ:KMDA
|
Research & Development
-$13.3m
|
CAGR 3-Years
-1%
|
CAGR 5-Years
-7%
|
CAGR 10-Years
0%
|
|
|
Urogen Pharma Ltd
NASDAQ:URGN
|
Research & Development
-$45.6m
|
CAGR 3-Years
1%
|
CAGR 5-Years
-4%
|
CAGR 10-Years
N/A
|
|
|
Entera Bio Ltd
NASDAQ:ENTX
|
Research & Development
-$4.5m
|
CAGR 3-Years
11%
|
CAGR 5-Years
12%
|
CAGR 10-Years
N/A
|
|
B
|
Bonus Biogroup Ltd
TASE:BONS
|
Research & Development
-₪19.6m
|
CAGR 3-Years
-22%
|
CAGR 5-Years
-15%
|
CAGR 10-Years
-15%
|
See Also
What is Rosetta Genomics Ltd's Research & Development?
Research & Development
-3.2m
USD
-3.2m
USD
Based on the financial report for Dec 31, 2016, Rosetta Genomics Ltd's Research & Development amounts to -3.2m USD.
What is Rosetta Genomics Ltd's Research & Development growth rate?
Research & Development CAGR 5Y
1%
1%
Over the last year, the Research & Development growth was -7%. The average annual Research & Development growth rates for Rosetta Genomics Ltd have been -22% over the past three years , 1% over the past five years .
You don't have any saved screeners yet
